Mirae Asset Global ETFs Holdings’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.1M Buy
563,248
+100,274
+22% +$6.98M 0.05% 346
2025
Q4
$30.7M Buy
462,974
+16,471
+4% +$1.06M 0.05% 360
2025
Q3
$30M Sell
446,503
-39,287
-8% -$3.11M 0.05% 352
2025
Q2
$42.4M Sell
485,790
-20,531
-4% -$1.61M 0.08% 239
2025
Q1
$34.6M Buy
506,321
+63,320
+14% +$5.17M 0.07% 271
2024
Q4
$34.5M Sell
443,001
-12,694
-3% -$940K 0.07% 273
2024
Q3
$30.5M Sell
455,695
-10,262
-2% -$843K 0.07% 284
2024
Q2
$52.8M Buy
+465,957
New +$58.9M 0.13% 166

Other funds holding DXCM

Mirae Asset Global ETFs Holdings's DXCM Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its DexCom (DXCM) stake by 22% in Q1 2026, buying an estimated $6.98M and bringing the position to 563,248 shares worth $35.1M. The position accounts for 0.05% of the portfolio, ranked #346.

Mirae Asset Global ETFs Holdings first reported a position in DXCM in Q2 2024 and has held it in 8 quarters since. The position peaked at $52.8M in Q2 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 563,248 shares of DexCom worth $35.1M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 100,274 DexCom shares in Q1 2026, an estimated $6.98M.
  • DexCom made up 0.05% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #346 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in DexCom in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's DexCom position peaked at $52.8M in Q2 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.